NUVISERTIB

UNII:	EOB0N7BOY4
Formula:	C₂₂H₂₅F₃N₄O
Preferred Substance Name:	NUVISERTIB
InChIKey:	XRNVABDYQLHODA-JCNLHEQBSA-N
GSRS Full Record:	EOB0N7BOY4 i

1361951-15-6
2-(TRANS-4-((3-(3-(TRIFLUOROMETHYL)PHENYL)IMIDAZO(1,2-B)PYRIDAZIN-6-YL)AMINO)CYCLOHEXYL)PROPAN-2-OL
4-((3-(3-(TRIFLUOROMETHYL)PHENYL)IMIDAZO(1,2-B)PYRIDAZIN-6-YL)AMINO) -TRANS-CYCLOHEXYL)PROPAN-2-OL
CYCLOHEXANEMETHANOL, .ALPHA.,.ALPHA.-DIMETHYL-4-((3-(3-(TRIFLUOROMETHYL)PHENYL)IMIDAZO(1,2-B)PYRIDAZIN-6-YL)AMINO)-, TRANS-
NUVISERTIB [INN]
NUVISERTIB [USAN]
SGI9481
SGI-9481
TP 3654 [WHO-DD]
TP3654
TP-3654
TRANS-.ALPHA.,.ALPHA.-DIMETHYL-4-((3-(3-(TRIFLUOROMETHYL)PHENYL)IMIDAZO(1,2-B)PYRIDAZIN-6-YL)AMINO)CYCLOHEXANEMETHANOL

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

NUVISERTIB

Synonyms and Mappings

Resources